10 Papers
8 Citations
Lu Wang is an academic researcher from Shandong University of Traditional Chinese Medicine. The author has contributed to research in topics: Breast cancer & Endometrial cancer. The author has an hindex of 5, co-authored 8 publications.
Chat about Author
Papers
Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis.
Jia Li,Ruijuan Liu,Shifeng Tang,Fubin Feng,Cun Liu,Lu Wang,Wenge Zhao,Tingting Zhang,Yan Yao,Xue Wang,Changgang Sun +10 more
TL;DR: Patients with endometriosis need to be closely observed and rechecked regularly to prevent malignant changes and are likely to be at increased risk for three gynecologic cancers.
49
Efficacy and safety of de-escalation bone- modifying agents for cancer patients with bone metastases: a systematic review and meta-analysis.
Cun Liu,Lu Wang,Lijuan Liu,Jing Zhuang,Shifeng Tang,Tiansong Zhang,Chao Zhou,Fubin Feng,Ruijuan Liu,Jinmei Zhang,Tingting Zhang,Chundi Gao,Huayao Li,Jia Li,Changgang Sun +14 more
TL;DR: A meta-analysis of randomized clinical trials appeared to show non-inferiority of the 12-weekly de-escalated therapy, and the results for bisphosphonates are more solid than for the receptor activator of nuclear factor-κB ligand (RANKL) antibodies.
Protein–protein interaction networks and different clustering analysis in Burkitt’s lymphoma
TL;DR: New insights are revealed into the molecular mechanisms underlying Burkitt's lymphoma, which may be novel therapeutic targets for disease management and may provide a bioinformatic basis for the further understanding of BL.
7
Subverted macrophages in the triple-negative breast cancer ecosystem.
Linxiao Shang,Yuting Zhong,Yan-Yun Yao,Cun-Bin Liu,Lu Wang,Wenfeng Zhang,Jingyang Liu,Xue Wang,Changgang Sun +8 more
- 01 Sep 2023
TL;DR: This work explored how macrophages are "subverted" to drive cancer evolution and the uniqueness of TAMs in TNBC progression and metastasis and discussed the rationale and available evidence for TAMs as potential targets for TNBC therapy.
3
Panaxadiol targeting IL2 inducible T cell kinase promotes T cell immunity in radiotherapy
TL;DR: Wang et al. as mentioned in this paper used protein-protein interaction network (PPIIN) to determine the key ingredients and targets of Ginseng on radiotherapy, and they found that Panaxadiol, as an active ingredient of GSE6871, can target ITK to participate in T cell signal receptor pathway.